![](/img/cover-not-exists.png)
Enhanced Efficacy and Confirmed Safety of a Two-Year Epicutaneous Immunotherapy (EPIT) Treatment of Peanut Allergy with Viaskin® Peanut: The Continuation of the Vipes Phase IIb Randomized Controlled Trial (RCT)
Sampson, Hugh A., Agbotounou, Wence, Thébault, Claude, Ruban, Charles, Martin, Laurent, Sussman, Gordon L., Brown-Whitehorn, Terri F., Yang, William H., Nadeau, Kari C., Cheema, Amarjit Singh, LeonardVolume:
137
Language:
english
Journal:
Journal of Allergy and Clinical Immunology
DOI:
10.1016/j.jaci.2015.12.1264
Date:
February, 2016
File:
PDF, 102 KB
english, 2016